Hepatitis B screening
Hepatitis B |
Diagnosis |
Treatment |
Case Studies |
Hepatitis B screening On the Web |
American Roentgen Ray Society Images of Hepatitis B screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Screening
Large-scale screening for HBV infection
Diagnosis of hepatitis is made by biochemical assessment of liver function. Initial laboratory evaluation should include: total and direct bilirubin, ALT, AST, alkaline phosphatase, prothrombin time, total protein, albumin, globulin, complete blood count, and coagulation studies.[1][2]
Recommendations for Persons Who Should Be Tested for HBV Infection: AASLD Practice Guidelines 2009[3]
“ | The following groups should be tested for HBV
infection:
|
” |
Recommendations for HCC Screening: AASLD Practice Guidelines 2009[3]
“ |
1. HBV carriers at high risk for HCC such as Asian men over 40 years and Asian women over 50 years of age, persons with cirrhosis, persons with a family history of HCC, Africans over 20 years of age, and any carrier over 40 years with persistent or intermittent ALT elevation and/or high HBV DNA level >2,000 IU/mL should be screened with US examination every 6-12 months. (Grade II-2) 2. For HBV carriers at high risk for HCC who are living in areas where US is not readily available, periodic screening with AFP should be considered. (Grade II-2) |
” |
References
- ↑ "Hepatitis B" (PDF).
- ↑ Fields, Bernard (2007). Fields virology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 0781760607.
- ↑ 3.0 3.1 Lok AS, McMahon BJ (2004). "[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]" (PDF). Romanian Journal of Gastroenterology. 13 (2): 150–4. PMID 15229781. Retrieved 2012-02-10. Unknown parameter
|month=
ignored (help)